Springhill Fund Asset Management (Hk) Co Ltd Top Holdings and 13F Report (2025) About Springhill Fund Asset Management (Hk) Co LtdInvestment ActivitySpringhill Fund Asset Management (Hk) Co Ltd has $20.87 million in total holdings as of March 31, 2025.Springhill Fund Asset Management (Hk) Co Ltd owns shares of 19 different stocks, but just 10 companies or ETFs make up 80% of its holdings.Approximately 64.51% of the portfolio was purchased this quarter.About 273.95% of the portfolio was sold this quarter.This quarter, Springhill Fund Asset Management (Hk) Co Ltd has purchased 17 new stocks and bought additional shares in 2 stocks.Springhill Fund Asset Management (Hk) Co Ltd sold shares of 4 stocks and completely divested from 11 stocks this quarter.Largest Holdings Verona Pharma $4,031,552Summit Therapeutics $2,397,882Janux Therapeutics $2,119,500Regeneron Pharmaceuticals $1,648,998Neurocrine Biosciences $1,505,487 Largest New Holdings this Quarter 86627T108 - Summit Therapeutics $2,397,882 Holding75886F107 - Regeneron Pharmaceuticals $1,648,998 Holding64125C109 - Neurocrine Biosciences $1,505,487 HoldingG50871105 - Jazz Pharmaceuticals $1,223,250 Holding04016X101 - argenx $678,277 Holding Largest Purchases this Quarter Summit Therapeutics 124,307 shares (about $2.40M)Regeneron Pharmaceuticals 2,600 shares (about $1.65M)Neurocrine Biosciences 13,612 shares (about $1.51M)Janux Therapeutics 48,900 shares (about $1.32M)Soleno Therapeutics 18,065 shares (about $1.29M) Largest Sales this Quarter Akero Therapeutics 131,275 shares (about $5.31M)Verona Pharma 71,953 shares (about $4.57M)Insmed 50,308 shares (about $3.84M)Cogent Biosciences 519,063 shares (about $3.11M) Sector Allocation Over TimeMap of 500 Largest Holdings ofSpringhill Fund Asset Management (Hk) Co Ltd Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorVRNAVerona Pharma$4,031,552$4,568,297 ▼-53.1%63,49919.3%MedicalSMMTSummit Therapeutics$2,397,882$2,397,882 ▲New Holding124,30711.5%MedicalJANXJanux Therapeutics$2,119,500$1,320,300 ▲165.2%78,50010.2%MedicalREGNRegeneron Pharmaceuticals$1,648,998$1,648,998 ▲New Holding2,6007.9%MedicalNBIXNeurocrine Biosciences$1,505,487$1,505,487 ▲New Holding13,6127.2%MedicalINSMInsmed$1,464,158$3,837,998 ▼-72.4%19,1927.0%MedicalSLNOSoleno Therapeutics$1,418,854$1,290,744 ▲1,007.5%19,8586.8%MedicalJAZZJazz Pharmaceuticals$1,223,250$1,223,250 ▲New Holding9,8535.9%MedicalAKROAkero Therapeutics$806,564$5,314,012 ▼-86.8%19,9253.9%MedicalARGXargenx$678,277$678,277 ▲New Holding1,1463.3%MedicalLLYEli Lilly and Company$673,943$673,943 ▲New Holding8163.2%MedicalPTGXProtagonist Therapeutics$621,861$621,861 ▲New Holding12,8593.0%MedicalTGTXTG Therapeutics$532,305$532,305 ▲New Holding13,5002.6%MedicalTARSTarsus Pharmaceuticals$363,494$363,494 ▲New Holding7,0761.7%MedicalASNDAscendis Pharma A/S$338,684$338,684 ▲New Holding2,1731.6%MedicalRYTMRhythm Pharmaceuticals$332,493$332,493 ▲New Holding6,2771.6%MedicalBNTXBioNTech$273,180$273,180 ▲New Holding3,0001.3%MedicalSWTXSpringWorks Therapeutics$260,235$260,235 ▲New Holding5,8971.2%MedicalCOGTCogent Biosciences$176,651$3,109,186 ▼-94.6%29,4910.8%MedicalLEGNLegend Biotech$0$6,208,632 ▼-100.0%00.0%MedicalCYTKCytokinetics$0$6,149,774 ▼-100.0%00.0%MedicalAZNAstraZeneca$0$5,012,280 ▼-100.0%00.0%MedicalVERAVera Therapeutics$0$4,626,526 ▼-100.0%00.0%MedicalMRUSMerus$0$3,523,790 ▼-100.0%00.0%MedicalCGEMCullinan Therapeutics$0$3,366,552 ▼-100.0%00.0%MedicalDYNE THERAPEUTICS INC$0$3,091,072 ▼-100.0%00.0%COMNRIXNurix Therapeutics$0$3,023,820 ▼-100.0%00.0%MedicalBRIGHT MINDS BIOSCIENCES INC$0$2,184,541 ▼-100.0%00.0%COM NEWBCYCBicycle Therapeutics$0$1,629,600 ▼-100.0%00.0%MedicalABIVAX SA$0$1,519,632 ▼-100.0%00.0%SPONSORED ADSShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
